As shown in Fig. 5e-h, cisplatin in combination with either USP10 inhibitor suppressed colony growth greater than either cisplatin or USP10 inhibitor alone, suggesting that targeting the activity of USP10 will sensitize NSCLC cells to cisplatin. Here, USP10 is linked to non-small cell lung carcinoma.